Industry Developments

BMI View: While we view a recent string of healthcare investments positively, we believe a deep-rooted political tradition of protectionism and more recent disputes surrounding Brazil's... 2011-10-24

BMI View: While BMI anticipated that Eli Lilly & Co's marketing, selling and administrative costs would impact the quarter's profitability, higher than expected costs of sales helped... 2011-10-21

Founded in 1876, Indianapolis-based Eli Lilly researches, develops and markets endocrinology, oncology, cardiovascular, neuroscience and animal health products. The company employs... 2011-10-21

BMI View: Abbott Laboratories' share price will outperform BMI's Pharma 20 Index over the next three months. The Illinois-based company will primarily benefit from the separation of... 2011-10-20

BMI View: Although testament to the region's increasing growth potential, we believe foreign investments into pharmacy chains and local pharmaceutical companies have far-reaching implications... 2011-10-19

BMI View: While viewed as a positive first step, we do not believe a proposed drug monitoring system will let Canadian drugmakers off the hook from the government's ongoing calls for... 2011-10-18

BMI View: While allegations that Brazil's ongoing outbreak of Chagas disease stems from failings at its regulator is embarrassing for state health officials, we believe increasing... 2011-10-17

Since BMI launched its Global Company Strategy reports in July 2011, stock markets worldwide have experienced a period of extreme uncertainty and share price weakness in light of the... 2011-10-17

BMI View: BMI's Pharmaceuticals and Healthcare Business Environment Ratings (BERs), which assess markets according to their risk/reward profile, show that the Americas have improved... 2011-10-14

BMI View: Where previous governments were unable to negotiate trade favourable terms, President Juan Manuel Santos has succeeded at ratifying Colombia's free trade agreement (FTA) with... 2011-10-13